Showing results (11-20 of 38) with videos related to
Sort By:
Pageof 4
NPJ Vaccines|January 31, 2026
Functional antibody signatures following therapeutic immunization in Simian and Human immunodeficiency virus infectionShlomi Ilan, Yannic Bartsch, Wonyeong Jung, et al.Journal of Virology|February 21, 2014
Capacity for infectious HIV-1 virion capture differs by envelope antibody specificityPinghuang Liu, Latonya D Williams, Xiaoying Shen, et al.Ebiomedicine|June 15, 2025
Vaccine-induced T cell responses correlate with reduced risk of severe COVID-19 in a placebo-controlled efficacy trialNina Hertoghs, Sanne Roels, Matthias Brückner, et al.NPJ Vaccines|January 6, 2024
Absolute quantitation of binding antibodies from clinical samplesChan Tang, Annemiek Verwilligen, Jerald Sadoff, et al.Journal of Virology|November 12, 2020
Deep Gene Sequence Cluster Analyses of Multi-Virus-Infected Mucosal Tissue Reveal Enhanced Transmission of Acute HIV-1Katja Klein, Immaculate Nankya, Gabrielle Nickel, et al.Ebiomedicine|November 14, 2025
Unbiased cell clustering analysis of vaccine-induced T cell responses in the Imbokodo HIV-1 vaccine trialValentin Voillet, Janine van Duijn, Kanika Vanshylla, et al.Retrovirology|October 3, 2014
Aggregate complexes of HIV-1 induced by multimeric antibodiesDaniel J Stieh, Deborah F King, Katja Klein, et al.Biorxiv : the Preprint Server for Biology|July 15, 2025
Design, Structure, and Immunogenicity of a Soluble Prefusion-stabilized EBV gB AntigenRyan S McCool, Cory M Acreman, Abigail E Powell, et al.Nature Communications|January 3, 2026
Structure and immunogenicity of an engineered soluble prefusion-stabilized EBV gB antigenRyan S McCool, Cory M Acreman, Abigail E Powell, et al.The Lancet. HIV|October 3, 2020
Safety and immunogenicity of two heterologous HIV vaccine regimens in healthy, HIV-uninfected adults (TRAVERSE): a randomised, parallel-group, placebo-controlled, double-blind, phase 1/2a studyLindsey R Baden, Daniel J Stieh, Michal Sarnecki, et al.Pageof 4